Kumagai Koji, Nakano Masahiro, Kutsuzawa Daisuke, Yamaguchi Yoshiaki, Minami Kentaro, Oshima Shigeru
The Division of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, Gunma, Japan.
The Division of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, Gunma, Japan.
J Cardiol. 2016 Jun;67(6):545-50. doi: 10.1016/j.jjcc.2015.07.010. Epub 2015 Aug 18.
This study aimed to evaluate an approach for an endpoint of non-inducibility using a combined high-dominant frequency (DF) and continuous complex fractionated atrial electrogram (CFAE) ablation following circumferential pulmonary vein isolation (PVI) in a sequential fashion, including linear ablation as compared to PVI alone.
A total of 84 non-paroxysmal patients with atrial fibrillation (AF) were investigated retrospectively. The AF patients were divided into two groups: patients with PVI following a combined high-DF and continuous CFAE ablation with linear ablation (substrate modification group, n=59) and those with PVI alone (n=25). DF sites of ≥8Hz and then continuous CFAE sites defined by fractionation intervals of ≤50ms were modified after PVI. The ablation endpoint was non-inducibility. Atrial tachyarrhythmias (ATs) could not be induced in 54 of 59 (92%) patients after a sequential ablation, and in 18 of 25 (64%) with PVI alone. The ATs freedom without antiarrhythmic drugs in the substrate modification group was significantly greater than that in those with PVI alone after 1 procedure during 12 months of follow-up (78.6% vs. 53.8%, log-rank test p=0.039).
This sequential approach using a substrate based ablation was associated with a better clinical long-term outcome as compared to PVI alone.
本研究旨在评估一种在环肺静脉隔离(PVI)后依次采用高主导频率(DF)与连续碎裂心房电图(CFAE)联合消融作为非诱发终点的方法,包括与单纯PVI相比的线性消融。
对84例非阵发性心房颤动(AF)患者进行回顾性研究。AF患者分为两组:在PVI后采用高DF与连续CFAE联合消融并进行线性消融的患者(基质改良组,n = 59)和单纯进行PVI的患者(n = 25)。在PVI后对≥8Hz的DF部位以及随后由≤50ms的碎裂间期定义的连续CFAE部位进行改良。消融终点为非诱发。序贯消融后,59例患者中有54例(92%)不能诱发房性心律失常(ATs),单纯PVI组25例中有18例(64%)不能诱发。在随访的12个月期间,基质改良组在1次手术后无抗心律失常药物情况下的ATs无发作率显著高于单纯PVI组(78.6%对53.8%,对数秩检验p = 0.039)。
与单纯PVI相比,这种基于基质的序贯消融方法具有更好的临床长期疗效。